Category Archives: Cardiovascular

Cardiovascular

Lupin Digital Health partners with ACC to deliver in-home cardiovascular care with DTx

Posted on by yun
24
Jul

As part of this collaboration, Lupin Digital Health will leverage ACC’s CardioSmart platform, guidelines, and workbooks to guide healthcare professionals and caregivers Lupin Digital Health and the American College of Cardiology (ACC) has announced collaboration to deliver in-home cardiovascular care with Digital Therapeutics (DTx) in India. This collaboration aims to accelerate the application and adoption […]

Continue reading →
Cardiovascular

Exclusion of chronic kidney disease patients from cardiovascular trials leaves significant evidence gaps

Posted on by yun
24
Jul

The higher risk of cardiovascular disease (CVD) among patients with chronic kidney disease (CKD) is not reflected in their poor level of inclusion in cardiovascular trials. The result has been the inability to ground treatment and prevention recommendations for such patients in evidence from randomized controlled trials (RCTs), considered the gold standard in evidence-based medicine. […]

Continue reading →
Cardiovascular

The Many Benefits Of Peanuts: From Helping In Weight Loss To Lowering Chances Of Cardiovascular Diseases

Posted on by yun

Walnuts, almonds, peanuts and other nuts are good for the heart. Peanuts contain abundant Protein, fat, and other beneficial nutrients. In the United States, peanuts are rarely consumed raw. Instead, they are more often consumed as peanut butter or roasted. Peanuts (Arachis hypogaea) are a legume that has its origin in South America. They go […]

Continue reading →
Cardiovascular

Daily Statin Medication Reduces Risk of Major Cardiovascular Events by More Than One-Third in People Living with HIV

Posted on by yun

BOSTON – The risk of cardiovascular diseases, including myocardial infarction and stroke, has been shown to be roughly twice as high in people living with HIV than the general population, creating an urgent need to test prevention strategies to ensure healthier, longer lives. In the first large-scale global clinical trial, Randomized Trial to Prevent Vascular […]

Continue reading →
Cardiovascular

Alnylam Announces Partnership with Roche to Co-Develop and Co-Commercialize Zilebesiran, an Investigational RNAi Therapeutic for the Treatment of Hypertension in Patients with High Cardiovascular Risk

Posted on by yun

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it has entered into a strategic agreement with Roche to develop and commercialize zilebesiran, Alnylam’s investigational RNAi therapeutic for the treatment of hypertension, which is currently in Phase 2 of development. The partnership allows for a bold development plan with […]

Continue reading →
Cardiovascular

Lee Health’s Dr. Paul DiGiorgi selected as president of the Florida Society of Thoracic and Cardiovascular Surgeons

Posted on by yun
24
Jul

Dr. Paul DiGiorgi Dr. Paul DiGiorgi Lee Health’s Dr. Paul DiGiorgi has been named the incoming president of the Florida Society of Thoracic and Cardiovascular Surgeons. Dr. DiGiorgi was previously secretary/treasurer. He will replace immediate past president Dr. Gregory J. England from Panama City Beach. As president, Dr. DiGiorgi will focus on continuing the Society’s […]

Continue reading →
Cardiovascular

Roche enters partnership with Alnylam to co-develop and co-commercialise RNAi therapeutic zilebesiran to treat hypertension in patients with high cardiovascular risk

Posted on by yun

Partnership combines Roche’s proven track record of successfully developing and launching innovative medicines worldwide with Alnylam’s leadership in RNAi therapeutics Zilebesiran, a Phase 2 RNAi therapeutic, has best-in-disease potential for patients with hypertension at high risk of cardiovascular morbidity and mortality, by robustly and durably lowering blood pressure Hypertension, the leading cause of cardiovascular disease, […]

Continue reading →
Cardiovascular

Adults with HIV can lower risk for cardiovascular disease with daily statin, study finds

Posted on by yun
24
Jul

July 24, 2023 2 min read Source/Disclosures Published by: Source: Grinspoon S, et al. Key REPRIEVE results and the utility of statins among people living with HIV: What have we learned? Presented at: International AIDS Society Conference on HIV Science; July 23-26, 2023; Brisbane, Australia. Disclosures: Grinspoon reports receiving consulting fees from Marathon Asset Management, […]

Continue reading →